ARCHIVES

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

This article is from The Cancer Letter archive.

Vol. 36 No. 46 | December 17, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

July 27, 2012

New Mexico, Missouri, Columbia Next for Review As comprehensive Centers; UCLA Decision In October

September 17, 1976

Most Comprehensive Centers Getting Core Grants Renewed

July 27, 1990

Senate confirms Crawford as FDA commissioner.

July 22, 2005

NIH Releases Digestive Diseases Research Plan

May 1, 2009

FDA Committee IK IL-2/LAK For Modified Group C

May 1, 1987